Variant of allele frequency: a decision-making tool in precision oncology?
Luca Boscolo Bielo
1, 2
,
Dario Trapani
1, 2
,
Matteo Repetto
1, 2, 3
,
Edoardo Crimini
1, 2
,
Carmine Valenza
1, 2
,
C. Belli
2
,
Carmen Criscitiello
1, 2
,
Antonio Marra
2
,
Vivek Subbiah
4
,
Giuseppe Curigliano
1, 2
2
4
Drug Development Unit, Sarah Cannon Research Institute, Nashville, TN, USA
|
Publication type: Journal Article
Publication date: 2023-12-01
scimago Q1
wos Q1
SJR: 4.727
CiteScore: 25.5
Impact factor: 17.5
ISSN: 24058033, 24058025
PubMed ID:
37704501
Cancer Research
Oncology
Abstract
Abstract
Precision oncology requires additional predictive biomarkers for targeted therapy selection. Variant allele frequency (VAF), measuring the proportion of variant alleles within a genomic locus, provides insights into tumor clonality in somatic genomic testing, yielding a strong rationale for targeting dominant cancer cell populations. The prognostic and predictive roles of VAF have been evaluated across different studies. Yet, the absence of validated VAF thresholds and a lack of standardization between sequencing assays currently hampers its clinical utility. Therefore, analytical and clinical validation must be further examined. This Review summarizes the evidence regarding the use of VAF as a predictive biomarker and discusses challenges and opportunities for its clinical implementation as a decision-making tool for targeted therapy selection.Found
Nothing found, try to update filter.
Found
Nothing found, try to update filter.
Top-30
Journals
|
1
2
3
|
|
|
Oncologist
3 publications, 5.66%
|
|
|
Annals of Oncology
3 publications, 5.66%
|
|
|
International Journal of Molecular Sciences
3 publications, 5.66%
|
|
|
Frontiers in Genetics
2 publications, 3.77%
|
|
|
Current Oncology
2 publications, 3.77%
|
|
|
Cancers
2 publications, 3.77%
|
|
|
Cancer Treatment Reviews
2 publications, 3.77%
|
|
|
Bioinformatics
2 publications, 3.77%
|
|
|
Frontiers in Oncology
2 publications, 3.77%
|
|
|
Scientific Reports
2 publications, 3.77%
|
|
|
Biological Research
1 publication, 1.89%
|
|
|
Journal of Personalized Medicine
1 publication, 1.89%
|
|
|
ESMO Real World Data and Digital Oncology
1 publication, 1.89%
|
|
|
Journal of Molecular Diagnostics
1 publication, 1.89%
|
|
|
Breast Cancer Research and Treatment
1 publication, 1.89%
|
|
|
Breast
1 publication, 1.89%
|
|
|
Leukemia and Lymphoma
1 publication, 1.89%
|
|
|
BMC Cancer
1 publication, 1.89%
|
|
|
ESMO Open
1 publication, 1.89%
|
|
|
Advances in Radiation Oncology
1 publication, 1.89%
|
|
|
Gastric Cancer
1 publication, 1.89%
|
|
|
American Journal of Ophthalmology Case Reports
1 publication, 1.89%
|
|
|
Clinics
1 publication, 1.89%
|
|
|
Clinical Oncology
1 publication, 1.89%
|
|
|
Thyroid Research
1 publication, 1.89%
|
|
|
Modern Pathology
1 publication, 1.89%
|
|
|
Heart Rhythm
1 publication, 1.89%
|
|
|
npj Precision Oncology
1 publication, 1.89%
|
|
|
Advances in Respiratory Medicine
1 publication, 1.89%
|
|
|
1
2
3
|
Publishers
|
2
4
6
8
10
12
14
16
18
|
|
|
Elsevier
17 publications, 32.08%
|
|
|
MDPI
10 publications, 18.87%
|
|
|
Springer Nature
10 publications, 18.87%
|
|
|
Oxford University Press
5 publications, 9.43%
|
|
|
Frontiers Media S.A.
4 publications, 7.55%
|
|
|
Taylor & Francis
2 publications, 3.77%
|
|
|
Cold Spring Harbor Laboratory
2 publications, 3.77%
|
|
|
BMJ
1 publication, 1.89%
|
|
|
World Scientific
1 publication, 1.89%
|
|
|
SAGE
1 publication, 1.89%
|
|
|
2
4
6
8
10
12
14
16
18
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.
Are you a researcher?
Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
53
Total citations:
53
Citations from 2024:
52
(98.11%)
Cite this
GOST |
RIS |
BibTex |
MLA
Cite this
GOST
Copy
Boscolo Bielo L. et al. Variant of allele frequency: a decision-making tool in precision oncology? // Trends in Cancer. 2023. Vol. 9. No. 12. pp. 1058-1068.
GOST all authors (up to 50)
Copy
Boscolo Bielo L., Trapani D., Repetto M., Crimini E., Valenza C., Belli C., Criscitiello C., Marra A., Subbiah V., Curigliano G. Variant of allele frequency: a decision-making tool in precision oncology? // Trends in Cancer. 2023. Vol. 9. No. 12. pp. 1058-1068.
Cite this
RIS
Copy
TY - JOUR
DO - 10.1016/j.trecan.2023.08.011
UR - https://doi.org/10.1016/j.trecan.2023.08.011
TI - Variant of allele frequency: a decision-making tool in precision oncology?
T2 - Trends in Cancer
AU - Boscolo Bielo, Luca
AU - Trapani, Dario
AU - Repetto, Matteo
AU - Crimini, Edoardo
AU - Valenza, Carmine
AU - Belli, C.
AU - Criscitiello, Carmen
AU - Marra, Antonio
AU - Subbiah, Vivek
AU - Curigliano, Giuseppe
PY - 2023
DA - 2023/12/01
PB - Elsevier
SP - 1058-1068
IS - 12
VL - 9
PMID - 37704501
SN - 2405-8033
SN - 2405-8025
ER -
Cite this
BibTex (up to 50 authors)
Copy
@article{2023_Boscolo Bielo,
author = {Luca Boscolo Bielo and Dario Trapani and Matteo Repetto and Edoardo Crimini and Carmine Valenza and C. Belli and Carmen Criscitiello and Antonio Marra and Vivek Subbiah and Giuseppe Curigliano},
title = {Variant of allele frequency: a decision-making tool in precision oncology?},
journal = {Trends in Cancer},
year = {2023},
volume = {9},
publisher = {Elsevier},
month = {dec},
url = {https://doi.org/10.1016/j.trecan.2023.08.011},
number = {12},
pages = {1058--1068},
doi = {10.1016/j.trecan.2023.08.011}
}
Cite this
MLA
Copy
Boscolo Bielo, Luca, et al. “Variant of allele frequency: a decision-making tool in precision oncology?.” Trends in Cancer, vol. 9, no. 12, Dec. 2023, pp. 1058-1068. https://doi.org/10.1016/j.trecan.2023.08.011.